Literature DB >> 15510172

Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE).

S M Kingsman, K Mitrophanous, J C Olsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15510172     DOI： 10.1038/sj.gt.3302417

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


× No keyword cloud information.
  25 in total

1.  Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.

Authors:  Albert Grinshpun; Reba Condiotti; Simon N Waddington; Michael Peer; Eli Zeig; Sima Peretz; Alina Simerzin; Janice Chou; Chi-Jiunn Pann; Hilla Giladi; Eithan Galun
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

Review 2.  New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes.

Authors:  Jozef Dulak; Anna Zagorska; Barbara Wegiel; Agnieszka Loboda; Alicja Jozkowicz
Journal:  Cell Biochem Biophys       Date:  2006       Impact factor: 2.194

Review 3.  New vectors and strategies for cardiovascular gene therapy.

Authors:  Agnieszka Jazwa; Alicja Jozkowicz; Jozef Dulak
Journal:  Curr Gene Ther       Date:  2007-02       Impact factor: 4.391

4.  Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.

Authors:  Michael J Castle; Heikki T Turunen; Luk H Vandenberghe; John H Wolfe
Journal:  Methods Mol Biol       Date:  2016

5.  Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.

Authors:  P S Becker; J A Taylor; G D Trobridge; X Zhao; B C Beard; S Chien; J Adair; D B Kohn; J E Wagner; A Shimamura; H-P Kiem
Journal:  Gene Ther       Date:  2010-05-20       Impact factor: 5.250

Review 6.  Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.

Authors:  Axel Schambach; Christopher Baum
Journal:  DNA Repair (Amst)       Date:  2007-05-07

Review 7.  Lentiviral delivery of short hairpin RNAs.

Authors:  N Manjunath; Haoquan Wu; Sandesh Subramanya; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2009-03-31       Impact factor: 15.470

8.  Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons.

Authors:  Kathie M Bishop; Eva K Hofer; Arpesh Mehta; Anthony Ramirez; Liangwu Sun; Mark Tuszynski; Raymond T Bartus
Journal:  Exp Neurol       Date:  2008-03-19       Impact factor: 5.330

9.  Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice.

Authors:  Shao-An Xue; Liquan Gao; Sharyn Thomas; Daniel P Hart; John Zhao Xue; Roopinder Gillmore; Ralf-Holger Voss; Emma Morris; Hans J Stauss
Journal:  Haematologica       Date:  2009-08-13       Impact factor: 9.941

10.  Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.

Authors:  Aurélie Bedel; Miguel Taillepierre; Véronique Guyonnet-Duperat; Eric Lippert; Pierre Dubus; Sandrine Dabernat; Thibaud Mautuit; Bruno Cardinaud; Catherine Pain; Benoît Rousseau; Magalie Lalanne; Cécile Ged; Yann Duchartre; Emmanuel Richard; Hubert de Verneuil; François Moreau-Gaudry
Journal:  Am J Hum Genet       Date:  2012-07-13       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.